(Reuters) - AstraZeneca's (AZN.L) chief executive has spent 2 million pounds on shares in the drugmaker, marking a vote of confidence in its prospects after the collapse of a $118 billion (68.78 billion pounds) takeover bid by Pfizer (PFE.N).
The British group said on Tuesday that Pascal Soriot purchased 46,200 AstraZeneca shares on June 30 at 43.45 pounds each, taking his holding to 197,781 shares - equivalent to 757 percent of his base salary.
Help employers find you! Check out all the jobs and post your resume.
